Factors affecting glucose tolerance in hereditary hemochromatosis

Clinical and Investigative Medicine

Volumn 20, Issue 2, 1997, Pages 110-118

  Hramiak, Irene M ^a,c   Finegood, Diane T ^b   Adams, Paul C ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FERRITIN BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEMOCHROMATOSIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; IRON OVERLOAD; LIVER CIRRHOSIS; PHLEBOTOMY; PRIORITY JOURNAL;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS; FERRITINS; GLUCOSE TOLERANCE TEST; HEMOCHROMATOSIS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; IRON; LIVER; LIVER CIRRHOSIS; MIDDLE AGED; PHLEBOTOMY; PROSPECTIVE STUDIES;

EID: 0030928517     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Finch CS, Finch CA. Idiopathic hemochromatosis an iron storage disease. Medicine 1955;34:381.
2. Saddi R, Feingold J. Idiopathic hemochromatosis: autosomal recessive disease. Rev Fr Etud Clin Biol 1969;14:238.
3. Kahn ST, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, et al. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Diabetes 1993;42:1663-72.
4. Kruszynska YT, Harry DS, Bergman RN, McIntyre N. Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients. Diabetologia 1993;36:121-8.
5. Stremmel W, Niederau C, Berger M, Kley H-K, Kruskemper H-L, Strohmeyer G. Abnormalities in estrogen, androgen, and insulin metabolism in idiopathic hemochromatosis. Ann N Y Acad Sci 1988;526:209-23.
6. Magnusson J, Tranberg KG. Impaired early insulin response to intravenous glucose in alcoholic liver cirrhosis. Scand J Gastroenterol 1987;22:301-7.
7. Bierens de Haan B, Scherrer JR, Stauffacher W, Pometta D. Iron excess, early glucose intolerance and impaired insulin secretion in idiopathic hemochromatosis. Eur J Clin Invest 1973;3:179-87.
8. Dymock IW, Cassar J, Pyke DA, Oakley WG, William R. Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of hemochromatosis. Am J Med 1972;52:203-10.
9. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110:1107-19.
10. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
11. Bergman RN. Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 1989;38:1512-27.
12. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987;79:790-800.
13. Finegood DT, Hramiak IM, Dupre J. A modified protocol for estimation of insulin sensitivity with the minimal-model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 1990;70:1538-49.
14. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimations of insulin sensitivity. Am J Physicians 1979;236:E667-77.
15. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsitivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986;23:113-22.
16. Lee A, Ader M, Bray G, Bergman R. Diurnal variation in glucose tolerance. Diabetes 1992;41:750-9.
17. Heding L. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975;2:541-8.
18. Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH. Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 1977;26:22-9.
19. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
20. DeFronzo RA. The triumvirate, B-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 1988;37: 667-87.
21. Brunzell JD, Robertson RP, Lerner RL. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 1976;42:222-9.
22. Martin B, Warram J, Krolewski A, Bergman R, Soeldner J, Kahn R. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Diabetologia 1992;340:925-9.
23. Eriksson J, Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L. Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 1989;321:337-43.
24. Ward WK, Johnston C, Beard C, Benedetti T, Halter JB, Porte D. Insulin resistance and impaired insulin secretion in subjects with histories of gestational diabetes mellitus. Diabetes 1985;34:861-9.
25. Defronzo RA. Glucose intolerance and aging. Diabetes Care 1981;4:493-501.
26. Feldman RD, Hramiak IM, Finegood DT, Behme MT. Parallel regulation of the local vascular and systemic metabolic effects of insulin. J Clin Endocrinol Metab 1995;80(5):1556-9.
27. Petrides AS, Groop L, Riely CA, Defronzo RA. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis. J Clin Invest 1991;88:561-70.
28. Dmochowski K, Finegood DT, Francombe W, Tyler B, Zinman B. Factors determining glucose tolerance in patients with thalassemia major. J Clin Endocrinol Metab 1993;77:478-83.
29. Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, et al. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med 1988;318: 809-14.
30. Rahier J, Loozen S, Goebbels RM, Abraham M. The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study. Diabetologia 1987;30:5-12.